Author:
Mo H.,Yang C.,Wang K.,Wang Y.,Huang M.,Murray B.,Qi X.,Sun S.-C.,Deshpande M.,Rhodes G.,Miller M. D.
Subject
Virology,Infectious Diseases,Hepatology
Reference32 articles.
1. Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia;Zeuzem;J Hepatol,2006
2. Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: analysis of individual patient data of six controlled trials. Eurohep Study Group for Viral Hepatitis;Schalm;Gastroenterology,1999
3. Hepatitis C advances in antiviral therapy: what is accepted treatment now?;McHutchison;J Gastroenterol Hepatol,2002
4. SCH 503034, a novel hepatitis C virus protease inhibitor, plus pegylated interferon alpha-2b for genotype 1 nonresponders;Sarrazin;Gastroenterology,2007
5. Robust antiviral activity of R1626, a novel nucleoside analog: a randomized, placebo-controlled study in patients with chronic hepatitis C;Roberts;Hepatology (Baltimore, MD),2008
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献